Location: New York, NY
CIK: 0001263508 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $19.96B (99.7% shares, 0.3% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INCY | Incyte Corporation | 30,762,330 | $3.487B | 17.5% | — | — | COM | 45337C102 |
| ONC | BeOne Medicines Ltd. | 8,801,567 | $2.508B | 12.6% | — | — | SPONSORED ADS | 07725L102 |
| RVMD | Revolution Medicines, Inc. | 11,443,357 | $2.143B | 10.7% | — | — | COM | 76155X100 |
| MDGL | Madrigal Pharmaceuticals, Inc. | 2,143,131 | $1.151B | 5.8% | — | — | COM | 558868105 |
| ACAD | ACADIA Pharmaceuticals Inc. | 42,912,904 | $1.086B | 5.4% | — | — | COM | 004225108 |
| KYMR | Kymera Therapeutics, Inc. | 8,657,242 | $993M | 5.0% | — | — | COM | 501575104 |
| INSM | Insmed Incorporated | 8,796,111 | $938M | 4.7% | — | — | COM PAR $.01 | 457669307 |
| CELC | Celcuity Inc. | 7,915,792 | $828M | 4.2% | — | — | COM | 15102K100 |
| KOD | Kodiak Sciences Inc. | 19,919,186 | $776M | 3.9% | — | — | COM | 50015M109 |
| RYTM | Rhythm Pharmaceuticals, Inc. | 5,604,483 | $622M | 3.1% | — | — | COM | 76243J105 |
| PRAX | Praxis Precision Medicines, Inc. | 1,753,198 | $587M | 2.9% | — | — | COM | 74006W207 |
| ALKS | Alkermes plc | 10,012,267 | $525M | 2.6% | — | — | SHS | G01767105 |
| SMMT | Summit Therapeutics Inc. | 32,786,348 | $478M | 2.4% | — | — | COM | 86627T108 |
| GRAL | GRAIL, Inc. | 4,028,614 | $275M | 1.4% | — | — | COM | 384747101 |
| ABCL | AbCellera Biologics Inc. | 33,012,138 | $259M | 1.3% | — | — | COM | 00288U106 |
| IMVT | Immunovant, Inc. | 5,435,220 | $209M | 1.0% | — | — | COM | 45258J102 |
| IDYA | IDEAYA Biosciences, Inc. | 5,010,030 | $187M | 0.9% | — | — | COM | 45166A102 |
| KNSA | Kiniksa Pharmaceuticals International, plc | 2,834,643 | $181M | 0.9% | — | — | ORD SHS CL A | G52694109 |
| ROIV | Roivant Sciences Ltd. | 4,716,831 | $167M | 0.8% | — | — | SHS | G76279101 |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 1,992,783 | $162M | 0.8% | — | — | COM | 04280A100 |
| IONS | Ionis Pharmaceuticals, Inc. | 2,047,727 | $162M | 0.8% | — | — | COM | 462222100 |
| EWTX | Edgewise Therapeutics, Inc. | 3,701,719 | $150M | 0.8% | — | — | COM | 28036F105 |
| REPL | Replimune Group, Inc. | 11,045,336 | $122M | 0.6% | — | — | COM | 76029N106 |
| NRIX | Nurix Therapeutics, Inc. | 4,658,556 | $113M | 0.6% | — | — | COM | 67080M103 |
| STOK | Stoke Therapeutics, Inc. | 3,336,697 | $109M | 0.5% | — | — | COM | 86150R107 |
| GLUE | Monte Rosa Therapeutics, Inc. | 4,345,736 | $105M | 0.5% | — | — | COM | 61225M102 |
| IMTX | Immatics N.V. | 9,508,565 | $96.32M | 0.5% | — | — | SHS | N44445109 |
| DNLI | Denali Therapeutics Inc. | 3,734,336 | $96.05M | 0.5% | — | — | COM | 24823R105 |
| CRNX | Crinetics Pharmaceuticals, Inc. | 2,351,465 | $87.99M | 0.4% | — | — | COM | 22663K107 |
| DNTH | Dianthus Therapeutics, Inc. | 852,164 | $83.07M | 0.4% | — | — | COM | 252828108 |
| GPCR | Structure Therapeutics Inc. | 1,432,529 | $76.88M | 0.4% | — | — | SPONSORED ADS | 86366E106 |
| — | Celcuity Inc. | 30,750,000 | $69.16M | 0.3% | — | — | Note 2.75% 8/1/2031 | 15102KAA8 |
| RAPP | Rapport Therapeutics, Inc. | 1,547,090 | $64.47M | 0.3% | — | — | COM | 75383L102 |
| ALMS | Alumis Inc. | 2,012,500 | $56.63M | 0.3% | — | — | COM | 022307102 |
| PRLD | Prelude Therapeutics Inc. | 10,123,824 | $53.96M | 0.3% | — | — | COM | 74065P101 |
| RLAY | Relay Therapeutics, Inc. | 2,826,783 | $52.89M | 0.3% | — | — | COM | 75943R102 |
| MIRM | Mirum Pharmaceuticals, Inc. | 445,975 | $52.21M | 0.3% | — | — | COM | 604749101 |
| BCYC | Bicycle Therapeutics plc | 10,885,357 | $46.15M | 0.2% | — | — | SPONSORED ADS | 088786108 |
| ELVN | Enliven Therapeutics, Inc. | 905,191 | $45.94M | 0.2% | — | — | COM | 29337E102 |
| CLDX | Celldex Therapeutics, Inc. | 1,182,611 | $44M | 0.2% | — | — | COM | 15117B202 |
| VRDN | Viridian Therapeutics, Inc. | 2,383,025 | $43.78M | 0.2% | — | — | COM | 92790C104 |
| DSGN | Design Therapeutics, Inc. | 2,678,430 | $38.76M | 0.2% | — | — | COM | 25056L103 |
| TRDA | Entrada Therapeutics, Inc. | 5,072,730 | $37.34M | 0.2% | — | — | COM | 29384C108 |
| SNSE | Faeth Therapeutics, Inc. | 1,286,411 | $32.16M | 0.2% | — | — | COM | 81728A207 |
| AKTS | Aktis Oncology, Inc. | 996,351 | $32.11M | 0.2% | — | — | COM | 01021M104 |
| NGNE | Neurogene Inc. | 991,691 | $31.19M | 0.2% | — | — | COM | 64135M105 |
| JBIO | Jade Biosciences, Inc. | 1,230,426 | $27.34M | 0.1% | — | — | COM | 008064206 |
| TSHA | Taysha Gene Therapies, Inc. | 4,004,756 | $27.27M | 0.1% | — | — | COM SHS | 877619106 |
| RCUS | Arcus Biosciences, Inc. | 844,816 | $26.05M | 0.1% | — | — | COM | 03969F109 |
| IRON | Disc Medicine, Inc. | 349,657 | $25.57M | 0.1% | — | — | COM | 254604101 |
| ABSI | Absci Corporation | 2,134,803 | $24.74M | 0.1% | — | — | COM | 00091E109 |
| GENB | Generate Biomedicines, Inc. | 1,423,602 | $24.02M | 0.1% | — | — | COM SHS | 370920100 |
| DBVT | DBV Technologies S.A. | 1,461,425 | $23.97M | 0.1% | — | — | SPONSORED ADS | 23306J309 |
| XENE | Xenon Pharmaceuticals Inc. | 370,208 | $22.35M | 0.1% | — | — | COM | 98420N105 |
| TECX | Tectonic Therapeutic, Inc. | 607,788 | $20.89M | 0.1% | — | — | COM | 878972108 |
| CERS | Cerus Corporation | 6,395,431 | $18.67M | 0.1% | — | — | COM | 157085101 |
| CTMX | CytomX Therapeutics, Inc. | 4,975,826 | $18.66M | 0.1% | — | — | COM | 23284F105 |
| DYN | Dyne Therapeutics, Inc. | 813,449 | $18.07M | 0.1% | — | — | COM | 26818M108 |
| CYTK | Cytokinetics, Incorporated | 211,267 | $18M | 0.1% | — | — | COM | 23282W605 |
| XNCR | Xencor, Inc. | 1,102,106 | $17.74M | 0.1% | — | — | COM | 98401F105 |
| SION | Sionna Therapeutics, Inc. | 400,000 | $17.6M | 0.1% | — | — | COM | 829401108 |
| NTLA | Intellia Therapeutics, Inc. | 930,232 | $15.74M | 0.1% | — | — | COM | 45826J105 |
| PBLS | Parabilis Medicines, Inc. | 500,000 | $13.69M | 0.1% | — | — | COM | 698955101 |
| MPLT | MapLight Therapeutics, Inc. | 364,705 | $13.07M | 0.1% | — | — | COM | 56565P103 |
| AVLN | Avalyn Pharma Inc. | 350,000 | $11.52M | 0.1% | — | — | COM SHS | 05348Y105 |
| EVMN | Evommune, Inc. | 847,390 | $11.26M | 0.1% | — | — | COM SHS | 30054Y107 |
| BNTX | BioNTech SE | 119,743 | $11.14M | 0.1% | — | — | SPONSORED ADS | 09075V102 |
| TNGX | Tango Therapeutics, Inc. | 333,333 | $10.42M | 0.1% | — | — | COM | 87583X109 |
| AVTX | Avalo Therapeutics, Inc. | 550,000 | $10.16M | 0.1% | — | — | COM | 05338F306 |
| SERA | Sera Prognostics, Inc. | 5,498,170 | $10.01M | 0.1% | — | — | CLASS A COM | 81749D107 |
| VSTM | Verastem, Inc. | 2,499,338 | $9.547M | 0.0% | — | — | COM | 92337C203 |
| SGMT | Sagimet Biosciences Inc. | 952,996 | $7.367M | 0.0% | — | — | COM SER A | 786700104 |
| EIKN | Eikon Therapeutics, Inc. | 555,555 | $7.25M | 0.0% | — | — | COM | 282564103 |
| LBRX | LB Pharmaceuticals Inc. | 200,000 | $6.491M | 0.0% | — | — | COM SHS | 50180M108 |
| VTVT | vTv Therapeutics, Inc. | 148,314 | $5.584M | 0.0% | — | — | CL A | 918385204 |
| WVE | Wave Life Sciences Ltd. | 822,638 | $4.78M | 0.0% | — | — | SHS | Y95308105 |
| TARA | Protara Therapeutics, Inc. | 971,614 | $3.712M | 0.0% | — | — | COM STK | 74365U107 |
| TCRX | TScan Therapeutics, Inc. | 2,784,792 | $2.729M | 0.0% | — | — | COM | 89854M101 |
| IMNM | Immunome, Inc. | 55,306 | $1.172M | 0.0% | — | — | COM | 45257U108 |
| SKYE | Skye Bioscience, Inc. | 1,575,243 | $1.092M | 0.0% | — | — | COM | 83086J200 |
| SANA | Sana Biotechnology, Inc. | 310,483 | $1.084M | 0.0% | — | — | COM | 799566104 |
| ALGS | Aligos Therapeutics, Inc. | 83,055 | $479K | 0.0% | — | — | COM | 01626L204 |
| TYRA | Tyra Biosciences, Inc. | 10,607 | $339K | 0.0% | — | — | COM | 90240B106 |
| SRZNW | Surrozen, Inc. Warrants @ $172.50 8/11/2026 (15 FOR 1) | 833,333 | $13,750 | 0.0% | — | — | W EXP 8/11/2026 | 86889P117 |